News

Investigators found that all patients had similar single surgery success rates but that minority patients had significantly worse vision outcomes and were more likely to have multiple retinal breaks.

In a conversation with David Hutton of Ophthalmology Times®, Ferhina S. Ali, MD, MPH, discussed the real world use of faricimab in the IRIS Registry during a presentation this week at Hawaiian Eye in Kauai Hawaii, focusing on the use of faricimab for the treatment of neovascular AMD and diabetic macular edema.

Topical formulation of TTHX1114 has potential to accelerate the healing of epithelial defects

Timely access to effective diagnosis and cross-linking is key to positive outcomes

Until new innovations began transforming the field a decade ago, ophthalmologists had a limited toolbox. This option allows ophthalmologists to provide positive outcomes for their patients.

Terms for the deal for AcuFocus were not revealed by the companies.

The ARVO Foundation Collaborative Research Fellowship is intended to promote international scientific interactions and innovative research.

According to researchers, factors that were associated with all type of visual impairment included older age, lower education level, and lower income were associated with all types of visual impairment.

Diabetic retinopathy is the leading cause of blindness in American adults, and a team of researchers believes the source of this damage may lie in the belly — mainly a leaky small intestine. A novel treatment can possibly prevent or reverse this damage.

A collaborative team of researchers with Oregon Health & Science University and Oregon State University are using lipid nanoparticles to target light-sensitive cells in the eye.

According to the U.S. Attorney’s Office for the Northern District of Georgia, Aarti D. Pandya, MD, settled allegations that she performed and billed for medically unnecessary cataract surgeries and diagnostic tests.

A study was conducted with the goal of evaluating a correlation between the number of peer-reviewed publications published before a residency and the subsequent peer-reviewed publications or career choices of doctors who graduated from an Ophthalmology residency program.

The EyeMobile will visit approximately 250 preschools to provide vision services to low-income families.

Viridian Therapeutics unveils positive data from its ongoing Phase 1/2 trial evaluating low dose VRDN-001 in patients diagnosed with TED.

The study could lead to early diagnosis and treatment of age-related macular degeneration.

According to the company, gene and protein expression of cytokines and chemokines after latanoprost+benzalkonium chloride treatment administered via the company’s microdose formulation decreased inflammation from preserved glaucoma solutions compared to drops.

A study by researchers at Oregon Health & Science University, the University of Chicago, Harvard University and Johns Hopkins University reveals more churn in workforce and greater reliance on physician assistants.

Continued education and financial incentives will become essential if biosimilars are to become a mainstay in ophthalmological markets, according to a recent report.

The results from an exchange trial demonstrated a second administration of travoprost intraocular implant and removal of the original implant was safe and well-tolerated, while the company also provided updates for several of its corneal health pipeline programs for the treatment of keratoconus and dry eye disease.

With the safety and efficacy of phacoemulsification having increased to the point that it is no longer standard practice to examine patients the day after surgery, clinicians may be unfamiliar with the potential causes of reduced vision when presented with a patient in the immediate postoperative period.

According to the company, it will initiate the NEXPEDE-1 Phase 2/3 clinical trial in subjects with PCED of various etiologies in the first quarter of 2023.

According to the company, the IC-8 Apthera IOL is a wavefront-filtering intraocular lens for unilateral implantation in the non-dominant eye in patients who have as much as 1.5 D of corneal astigmatism in the implanted eye.

For ocular herpetic infection, topical antiviral medication alone is not sufficient. Investigators found that systemic antiherpetic treatment is needed to prevent recurrence and graft failure after PK.

The company will add programs in diabetic macular edema and myopia as it completes pre-clinical studies.

BVS Sight Inc. was created through a partnership between Boomerang Ventures and Purdue Research Foundation.

The Alcon Children’s Vision Center is available for follow-up appointments and ongoing eye care, all free of charge for qualified students in need, from Pre-Kindergarten through Grade 12.

According to the company, the launch of the presbyopia phase 3 program is supported by positive clinical results that demonstrated durable efficacy and a favorable safety profile.

The researchers conducted a retrospective chart review of patients with typical exudative AMD that had been treated with anti-VEGF therapy injections.